Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Jul 21, 2018 at 10:57 AM EDT

6 Speculative BioHealth Analyst Stocks That Could Rally 50% to 300%

Some biotech and biohealth stocks are receiving analyst coverage calling for 50%, 100%, 200% and even 300% upside price targets.…

Chris Lange | Jul 20, 2018 at 12:00 PM EDT

PTC Therapeutics Wins Big With Agilis Biotherapeutics Acquisition

PTC Therapeutics shares made a handy gain on Friday after the firm announced that it would be acquiring Agilis Biotherapeutics.

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

Chris Lange | Jul 19, 2018 at 10:25 AM EDT

Mersana Cries for Mercy

Mersana Therapeutics shares took a massive dive on Thursday morning after the company announced that the FDA put a partial…

Chris Lange | Jul 18, 2018 at 1:40 PM EDT

Rubius Therapeutics Enters the Market With a Bang

Rubius Therapeutics entered the market with a bang in its initial public offering.

Chris Lange | Jul 18, 2018 at 10:00 AM EDT

Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study

Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in…

Chris Lange | Jul 17, 2018 at 12:15 PM EDT

Why Voyager Therapeutics Shares Are Surging

Voyager Therapeutics shares saw a handy gain on Tuesday after the company announced that it received some feedback from the…

Chris Lange | Jul 17, 2018 at 10:05 AM EDT

Why UnitedHealth Earnings Aren’t Enough

UnitedHealth Group Inc. (NYSE: UNH) released its second quarter financial results before the markets opened on Tuesday. The company said…

Chris Lange | Jul 17, 2018 at 8:45 AM EDT

Are Johnson & Johnson Q2 Earnings Good Enough?

Johnson & Johnson reported better-than-expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 16, 2018 at 1:35 PM EDT

What to Watch For in UnitedHealth Earnings

UnitedHealth is scheduled to report its second-quarter financial results before the markets open on Tuesday.

Chris Lange | Jul 16, 2018 at 10:25 AM EDT

What to Expect When Johnson & Johnson Reports Tuesday Morning

Johnson & Johnson is set to report its second-quarter financial results before the markets open on Tuesday.

Chris Lange | Jul 16, 2018 at 10:05 AM EDT

Why Tonix Pharmaceuticals Is Winning Big on Monday

Tonix Pharmaceuticals saw its shares make a solid gain to start off the week after the company announced an update…

Chris Lange | Jul 13, 2018 at 11:11 AM EDT

FDA Warns of Potential Hoax Letters

The FDA issued a warning early on Friday that consumers should be on the lookout for criminals forging FDA warning…

Chris Lange | Jul 13, 2018 at 10:30 AM EDT

Will Acceleron Pharma Momentum Continue After New FDA Nod?

Acceleron Pharma shares dipped on Friday after the company provided an update on an orphan drug designation from the FDA.

Chris Lange | Jul 12, 2018 at 11:40 AM EDT

How Zogenix Is Winning Big With Late-Stage Seizure Study

Zogenix shares made a solid gain on Thursday after the company announced positive results from its late-stage seizure trial.

1 … 125 126 127 128 129 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

6 Speculative BioHealth Analyst Stocks That Could Rally 50% to 300%

PTC Therapeutics Wins Big With Agilis Biotherapeutics Acquisition

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Mersana Cries for Mercy

Rubius Therapeutics Enters the Market With a Bang

Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study

Why Voyager Therapeutics Shares Are Surging

Why UnitedHealth Earnings Aren’t Enough

Are Johnson & Johnson Q2 Earnings Good Enough?

What to Watch For in UnitedHealth Earnings

What to Expect When Johnson & Johnson Reports Tuesday Morning

Why Tonix Pharmaceuticals Is Winning Big on Monday

FDA Warns of Potential Hoax Letters

Will Acceleron Pharma Momentum Continue After New FDA Nod?

How Zogenix Is Winning Big With Late-Stage Seizure Study

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

6 Speculative BioHealth Analyst Stocks That Could Rally 50% to 300%

PTC Therapeutics Wins Big With Agilis Biotherapeutics Acquisition

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Mersana Cries for Mercy

Rubius Therapeutics Enters the Market With a Bang

Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study

Why Voyager Therapeutics Shares Are Surging

Why UnitedHealth Earnings Aren’t Enough

Are Johnson & Johnson Q2 Earnings Good Enough?

What to Watch For in UnitedHealth Earnings

What to Expect When Johnson & Johnson Reports Tuesday Morning

Why Tonix Pharmaceuticals Is Winning Big on Monday

FDA Warns of Potential Hoax Letters

Will Acceleron Pharma Momentum Continue After New FDA Nod?

How Zogenix Is Winning Big With Late-Stage Seizure Study

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how